NCT02221141CompletedNot Applicable
Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
Laurence Gabriel1 site in 1 country120 target enrollmentStarted: December 2013Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation
Study Overview
Brief Summary
The purpose of this study is to determine the prevalence in Belgium of Fabry disease in patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to determine in Fabry patients which was the most frequently initial symptom.
Actually the early diagnosis is important because a treatment exists that can prevent future complications.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Other
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •unexplained left ventricular hypertrophy
Exclusion Criteria
- •isolated septal hypertrophy
Outcomes
Primary Outcomes
Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation
Time Frame: 1 day
Secondary Outcomes
No secondary outcomes reported
Investigators
Laurence Gabriel
Dr Laurence GABRIEL
Centre Hospitalier Universitaire UCLouvain Namur
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic CardiomyopathyLeft Ventricular HypertrophyNCT01198899University Hospital, Ghent540
Recruiting
Not Applicable
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular HypertrophyLeft Ventricular HypertrophyHypertrophic CardiomyopathyFabry DiseaseNCT06169358Qilu Hospital of Shandong University627
Active, not recruiting
Not Applicable
Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical ScoreFabry Disease, Cardiac VariantHCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseFabry DiseaseLysosomal Storage DiseasesNCT04943991Wuerzburg University Hospital200
Completed
Not Applicable
The epidemiologic research of Fabry disease for hypertrophic cardiomyopathy in Yokohama.Fabry diseaseJPRN-UMIN000015593Yokohama City University Hospital480
Unknown
Not Applicable
Study of the Prevalence of Fabry Disease in French Dialysis PatientsEnd Stage Renal DiseaseRenal DialysisFabry DiseaseNCT02843334Hospices Civils de Lyon6,000